In our study, Trem2 knockdown contributed to the reduced Pneumocystis burden and lung injury, which underlines the possibility that targeting Trem2 could be a new approach for control of Pneumocystis infection beyond neurodegenerative disease, obesity-related metabolic syndrome, and cancer. This evidence concerns the gene TREM2 and Pneumocystis infectious disease.